Shanghai Sailun Biotech Co. Ltd. logo

Shanghai Sailun Biotech Co. Ltd. (688163)

Market Closed
11 Aug, 06:57
SSE SSE
¥
32. 60
+0.37
+1.148%
¥
1.95B Market Cap
- P/E Ratio
0.48% Div Yield
1.16M Volume
- Eps
¥ 32.23
Previous Close
Add Transaction
Day Range
31.6 33.58
Year Range
21.2 52.88
Want to track 688163 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688163 closed today higher at ¥32.6, an increase of 1.148% from yesterday's close, completing a monthly decrease of -32.8804% or -¥15.97. Over the past 12 months, 688163 stock gained 49.7474%.
688163 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

688163 Chart

People also search for

Jiangsu GDK Biotechnology Co., Ltd.
¥ 15.59
-1.4539%
HTPB CSI TC Medical ETF
¥ 0.98
-0.5066%
Careray Digital Medical Co., Ltd.
¥ 47.6
+0.1684%
Shanghai Rightongene Biotechnology Co., Ltd.
¥ 24.12
-1.9512%
Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd.
¥ 21.5
-0.9217%

Shanghai Sailun Biotech Co. Ltd. (688163) FAQ

What is the stock price today?

The current price is ¥32.60.

On which exchange is it traded?

Shanghai Sailun Biotech Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688163.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.48%.

What is its market cap?

As of today, the market cap is 1.95B.

Has Shanghai Sailun Biotech Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Shanghai Sailun Biotech Co. Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Tiejiong Fan CEO
SSE Exchange
CNE1000059X8 ISIN
CN Country
- Employees
29 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Shanghai Serum Bio-Technology Co., Ltd. is a biotechnology company focused on the research, development, manufacturing, and distribution of antitoxin and antiserum products. Established in 1999, the company has positioned itself as a leading entity in the field within China, operating from its base in Shanghai. Its commitment to enhancing public health is evident through its dedicated efforts in producing vital immunoglobulin and serum products to combat various diseases and toxic exposures.

Products and Services

  • Equine Anti-Tetanus Immunoglobulin

    This product is developed for the prevention and treatment of tetanus. Utilizing equine antibodies, it provides passive immunity to individuals exposed to the bacteria causing tetanus, offering critical protection in both post-injury prophylaxis and therapeutic contexts.

  • Anti-Venin

    Shanghai Serum Bio-Technology's anti-venin products are designed to neutralize the effects of venom from snakes and other venomous animals. These products are crucial in areas where snake bites or venomous exposures are common, providing a life-saving treatment for affected individuals.

  • Anti-Rabies Serum

    The anti-rabies serum provided by the company is an essential medical intervention against rabies, a deadly virus transmitted through the bites of infected animals. This product is part of the post-exposure prophylaxis regimen, aiming to prevent the virus from causing rabies in individuals with suspected exposure.

Contact Information

Address: No. 1288, Huaqing Road, Shanghai, China, 201707
Phone: 86 21 6076 0783